{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acute+Psychosis", "query": { "condition": "Acute Psychosis" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 65, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acute+Psychosis&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-11T01:24:44.606Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00044044", "title": "A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Lurasidone 20 mg", "type": "DRUG" }, { "name": "Lurasidone 40mg", "type": "DRUG" }, { "name": "Lurasidone 80 mg", "type": "DRUG" }, { "name": "Haloperidol 10mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 356, "start_date": "2002-07", "completion_date": "2003-05", "has_results": true, "last_update_posted_date": "2014-04-17", "last_synced_at": "2026-09-11T01:24:44.606Z", "location_count": 34, "location_summary": "Birmingham, Alabama • Cerritos, California • Garden Grove, California + 26 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00044044" }, { "nct_id": "NCT01663532", "title": "Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Aripiprazole IM Depot", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 340, "start_date": "2012-10", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2015-02-16", "last_synced_at": "2026-09-11T01:24:44.606Z", "location_count": 43, "location_summary": "Little Rock, Arkansas • Springdale, Arkansas • Anaheim, California + 32 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Springdale", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Carson", "state": "California" }, { "city": "Escondido", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01663532" }, { "nct_id": "NCT05227690", "title": "A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Emraclidine 10 mg", "type": "DRUG" }, { "name": "Emraclidine 30 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 385, "start_date": "2022-06-30", "completion_date": "2024-08-26", "has_results": true, "last_update_posted_date": "2025-09-17", "last_synced_at": "2026-09-11T01:24:44.606Z", "location_count": 21, "location_summary": "Little Rock, Arkansas • Anaheim, California • Garden Grove, California + 18 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Lemon Grove", "state": "California" }, { "city": "Montclair", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05227690" }, { "nct_id": "NCT00694707", "title": "Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Cariprazine", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 732, "start_date": "2008-06-30", "completion_date": "2009-08-31", "has_results": true, "last_update_posted_date": "2019-06-12", "last_synced_at": "2026-09-11T01:24:44.606Z", "location_count": 18, "location_summary": "Costa Mesa, California • Long Beach, California • Oceanside, California + 14 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Paramount", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00694707" }, { "nct_id": "NCT01234779", "title": "A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "bitopertin [RO4917838]", "type": "DRUG" }, { "name": "olanzapine", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 301, "start_date": "2011-02", "completion_date": "2012-09", "has_results": false, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-09-11T01:24:44.606Z", "location_count": 19, "location_summary": "Little Rock, Arkansas • Cerritos, California • Oceanside, California + 16 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Cerritos", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Pico Rivera", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01234779" }, { "nct_id": "NCT01490086", "title": "RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Schizophrenia", "Schizoaffective Disorder" ], "interventions": [ { "name": "RP5063", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "aripiprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Reviva Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 234, "start_date": "2011-12", "completion_date": "2013-03", "has_results": true, "last_update_posted_date": "2025-08-08", "last_synced_at": "2026-09-11T01:24:44.606Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01490086" }, { "nct_id": "NCT01469039", "title": "A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "ALKS 9072", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alkermes, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 623, "start_date": "2011-12", "completion_date": "2014-03", "has_results": true, "last_update_posted_date": "2019-01-30", "last_synced_at": "2026-09-11T01:24:44.606Z", "location_count": 26, "location_summary": "Little Rock, Arkansas • Springdale, Arkansas • Cerritos, California + 20 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Springdale", "state": "Arkansas" }, { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01469039" }, { "nct_id": "NCT00580125", "title": "Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "PF-00217830", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Aripiprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 164, "start_date": "2007-11", "completion_date": "2008-09", "has_results": false, "last_update_posted_date": "2012-04-18", "last_synced_at": "2026-09-11T01:24:44.606Z", "location_count": 8, "location_summary": "Garden Grove, California • Torrance, California • Washington D.C., District of Columbia + 5 more", "locations": [ { "city": "Garden Grove", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Bridgeton", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00580125" }, { "nct_id": "NCT01175135", "title": "An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "PF-02545920", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 259, "start_date": "2010-10", "completion_date": "2011-08", "has_results": true, "last_update_posted_date": "2018-05-22", "last_synced_at": "2026-09-11T01:24:44.606Z", "location_count": 38, "location_summary": "Little Rock, Arkansas • Anaheim, California • Escondido, California + 23 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Garden Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01175135" }, { "nct_id": "NCT00309699", "title": "A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder", "Mood Disorders" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" }, { "name": "Paliperidone ER", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 493, "start_date": "2006-04", "completion_date": "2007-11", "has_results": false, "last_update_posted_date": "2014-06-20", "last_synced_at": "2026-09-11T01:24:44.606Z", "location_count": 22, "location_summary": "Cerritos, California • Garden Grove, California • Oceanside, California + 19 more", "locations": [ { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Bradenton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00309699" } ] }